000 01306 a2200361 4500
005 20250514033631.0
264 0 _c20030507
008 200305s 0 0 eng d
022 _a1465-6566
024 7 _a10.1517/14656566.3.6.755
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMekhail, Tarek M
245 0 0 _aPaclitaxel in cancer therapy.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cJun 2002
300 _a755-66 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xadverse effects
700 1 _aMarkman, Maurie
773 0 _tExpert opinion on pharmacotherapy
_gvol. 3
_gno. 6
_gp. 755-66
856 4 0 _uhttps://doi.org/10.1517/14656566.3.6.755
_zAvailable from publisher's website
999 _c11933664
_d11933664